Abstract:This review provides a comprehensive overview of the current state of probiotic research, covering a wide range of topics, including strain identification, functional characterization, preclinical and clinical evaluations, mechanisms of action, therapeutic applications, manufacturing considerations, and future directions. The screening process for potential probiotics involves phenotypic and genomic analysis to identify strains with health-promoting properties while excluding those with any factor that could be harmful to the host. In vitro assays for evaluating probiotic traits such as acid tolerance, bile metabolism, adhesion properties, and antimicrobial effects are described. The review highlights promising findings from in vivo studies on probiotic mitigation of inflammatory bowel diseases, chemotherapy-induced mucositis, dysbiosis, obesity, diabetes, and bone health, primarily through immunomodulation and modulation of the local microbiota in human and animal models. Clinical studies demonstrating beneficial modulation of metabolic diseases and human central nervous system function are also presented. Manufacturing processes significantly impact the growth, viability, and properties of probiotics, and the composition of the product matrix and supplementation with prebiotics or other strains can modify their effects. The lack of regulatory oversight raises concerns about the quality, safety, and labeling accuracy of commercial probiotics, particularly for vulnerable populations. Advancements in multi-omics approaches, especially probiogenomics, will provide a deeper understanding of the mechanisms behind probiotic functionality, allowing for personalized and targeted probiotic therapies. However, it is crucial to simultaneously focus on improving manufacturing practices, implementing quality control standards, and establishing regulatory oversight to ensure the safety and efficacy of probiotic products in the face of increasing therapeutic applications.

Genomic Insights into Probiotic Metabolism of Dietary Carbohydrates, Proteins, and Fats

Targeting gut microbiota and metabolism as the major probiotic mechanism-An evidence-based review

Gene editing and genetic engineering approaches for advanced probiotics: A review

Advanced probiotics: bioengineering and their therapeutic application

Exploring the Multifaceted Therapeutic Potential of Probiotics: A Review of Current Insights and Applications

High-fidelity Gut Metagenome: A New Insight of Identification of Functional Probiotics

Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host

A comprehensive review of the characterization, host interactions, and stabilization advancements on probiotics: Addressing the challenges in functional food diversification

Probiotic Species in the Modulation of Gut Microbiota: An Overview

Systematic evaluation of genome-wide metabolic landscapes in lactic acid bacteria reveals diet-induced and strain-specific probiotic idiosyncrasies

Unlocking the Potential of Probiotics: A Comprehensive Review on Research, Production, and Regulation of Probiotics

Exploring the interaction and impact of probiotic and commensal bacteria on vitamins, minerals and short chain fatty acids metabolism

Biotechnological Applications of Probiotics: A Multifarious Weapon to Disease and Metabolic Abnormality

Integrating metabolomics, bionics, and culturomics to study probiotics-driven drug metabolism.

Mechanisms of Probiotic Bacillus Against Enteric Bacterial Infections

Metabolic Engineering Approaches for Improvement of Probiotics Functionality

Not just a gut feeling: a deep exploration of functional bacterial metabolites that can modulate host health

How Do Diet Patterns, Single Foods, Prebiotics and Probiotics Impact Gut Microbiota?

Advancements in gene editing technologies for probiotic-enabled disease therapy

Microbial metabolites as modulators of host physiology

Molecular insights into probiotic mechanisms of action employed against intestinal pathogenic bacteria